Thyroid Disease Clinical Trial
Official title:
Are Narcotic Pain Medications Necessary Following Thyroidectomy and Parathyroidectomy
The purpose of this study is to evaluate the use of a non-narcotic, postoperative pain management regimen on patients undergoing thyroidectomy and parathyroidectomy.
The purpose of this study is to evaluate the use of a non-narcotic, postoperative pain
management regimen for patients undergoing thyroidectomy and parathyroidectomy. The
investigators hypothesize that participants receiving non-narcotic pain regimens will have
equivalent pain control and satisfaction to those who receive narcotic pain medicines.
The primary objective will be to identify if there is a difference in average perceived
postoperative pain scores between participants who do and do not receive narcotic pain
medications. Secondary outcomes will include need for breakthrough pain medications, patient
satisfaction scores and the need to call the surgeon office for additional pain medications.
The participant will undergo total thyroidectomy, partial thyroidectomy or parathyroidectomy
per the standard of care. The study will have no influence on the surgical procedure
performed.
Following the surgery, postoperative analgesia regimens will be prescribed based on study
randomization.
Narcotic group regimen (63 patients):
- Tylenol tablet 1000 mg by mouth every 8 hours alternating with
- Ibuprofen tablet 800 mg by mouth every 8 hours
- Oxycodone 5 mg by mouth every 6 hours as needed for pain, #10 tablets
Non-narcotic group regimen (63 patients):
- Tylenol tablet 1000 mg by mouth every 8 hours alternating with
- Ibuprofen tablet 800 mg by mouth every 8 hours
Participants will be asked to complete a survey each day for the initial 5 days
postoperatively. Survey data includes:
- Average pain level using the 10-point visual analogue scale
- Ease of following the pain regimen using a 3-point liker scale
- Total dose of oral narcotics converted into oral morphine equivalents that were taken by
participants post-operatively
- If the patient needed to call the office due to inadequately controlled pain
If the participants do not have adequate pain control with the non-narcotic regimen, they may
be prescribed additional narcotic pain medication at the discretion of the PI and remain
enrolled in the study.
The investigators will also review participants charts for information regarding any
postoperative office calls regarding postoperative needs (i.e. for pain medications).
The medical surgical information below is gathered as standard of care for each surgical
procedure and will also be collected as part of this procedure:
- Patient name, medical record number
- Patient demographics (age, gender, BMI, ASA score)
- Past medical History
- Past surgical history
- Past social history
- Preoperative medications (including steroids, anticoagulation, opioid use)
- Pre-operative diagnosis
- Procedure performed and pain medications administered in the post-ambulatory care unit
- Postoperative complications including need for readmission within 30 days
- Length of stay in hospital
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05836246 -
The Development of Quantitative Ultrasound Imaging Software Platform
|
||
Active, not recruiting |
NCT05579782 -
Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy
|
N/A | |
Completed |
NCT04124705 -
A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants
|
Phase 2 | |
Enrolling by invitation |
NCT06028282 -
Post-RAI Therapy Dosimetry and Quality Assessment of Target Tissue Dosing
|
||
Recruiting |
NCT05626010 -
Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Thyroidectomy
|
N/A | |
Completed |
NCT01805856 -
Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery
|
N/A | |
Recruiting |
NCT05117853 -
Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy
|
Phase 3 | |
Completed |
NCT00592605 -
Thyroid Disease Serum Repository
|
N/A | |
Completed |
NCT04344886 -
Optimization and Individualization of Diagnostic Scintigraphy Protocol and Minimally Invasive Radio-guided Parathyroid Surgery
|
N/A | |
Completed |
NCT03012438 -
NIRF for Parathyroid Visualization: a Pilot Study
|
N/A | |
Completed |
NCT00846755 -
Thyroid Disease in Pregnancy: Case Finding Versus Universal Screening
|
N/A | |
Completed |
NCT04635813 -
The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study
|
||
Not yet recruiting |
NCT05432050 -
Bispectral Index and Patient State Index During General Anesthesia With Remimazolam
|
||
Recruiting |
NCT03191188 -
A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients
|
N/A | |
Recruiting |
NCT06296420 -
Dysphagia After Thyroidectomy
|
||
Completed |
NCT02981095 -
Effect of Bupivacaine Application on Postthyroidectomy Pain
|
N/A | |
Completed |
NCT01539499 -
Complications of Endocrine Surgery: Data From the United HealthSystem Consortium
|
N/A | |
Completed |
NCT05421559 -
Transection of Sternothyroid Muscle Increases the Rate of Exposure of the External Laryngeal Nerve During Thyroidectomy
|
N/A | |
Completed |
NCT00054756 -
Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
|
Phase 2 | |
Completed |
NCT02951000 -
Platysma Trial - Platysma Suturing Versus no Sutures for Wound Closure After Primary Thyroid Surgery
|
N/A |